GW&K Investment Management LLC Has $57.45 Million Stock Position in Integer Holdings Co. (NYSE:ITGR)

GW&K Investment Management LLC trimmed its holdings in shares of Integer Holdings Co. (NYSE:ITGR) by 17.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 433,531 shares of the medical equipment provider’s stock after selling 88,600 shares during the period. GW&K Investment Management LLC owned 1.29% of Integer worth $57,452,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Blue Trust Inc. raised its holdings in Integer by 4.4% in the fourth quarter. Blue Trust Inc. now owns 1,689 shares of the medical equipment provider’s stock worth $220,000 after purchasing an additional 71 shares during the period. HighTower Advisors LLC boosted its holdings in shares of Integer by 0.8% in the third quarter. HighTower Advisors LLC now owns 12,041 shares of the medical equipment provider’s stock valued at $1,579,000 after buying an additional 90 shares during the period. State of New Jersey Common Pension Fund D increased its position in shares of Integer by 0.9% during the fourth quarter. State of New Jersey Common Pension Fund D now owns 15,722 shares of the medical equipment provider’s stock worth $2,083,000 after acquiring an additional 140 shares in the last quarter. Mather Group LLC. raised its holdings in shares of Integer by 304.3% during the fourth quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 143 shares during the period. Finally, Exchange Traded Concepts LLC boosted its stake in Integer by 2.6% in the 4th quarter. Exchange Traded Concepts LLC now owns 5,800 shares of the medical equipment provider’s stock worth $769,000 after purchasing an additional 145 shares during the period. Institutional investors own 99.29% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ITGR. Benchmark upped their price objective on Integer from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Friday, February 21st. Truist Financial increased their target price on shares of Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. KeyCorp lifted their price target on shares of Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Wells Fargo & Company restated an “overweight” rating and set a $160.00 price objective on shares of Integer in a research note on Tuesday, December 3rd. Finally, Oppenheimer downgraded Integer from an “outperform” rating to a “market perform” rating in a research report on Friday, February 21st. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $147.67.

Integer Trading Down 1.8 %

Shares of NYSE:ITGR opened at $124.00 on Friday. The company has a 50-day simple moving average of $137.06 and a 200 day simple moving average of $132.78. The company has a market capitalization of $4.17 billion, a P/E ratio of 36.91, a price-to-earnings-growth ratio of 1.72 and a beta of 1.13. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. Integer Holdings Co. has a 52-week low of $105.14 and a 52-week high of $146.36.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). The business had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. Sell-side analysts forecast that Integer Holdings Co. will post 6.01 earnings per share for the current year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.